Nathalie Adda
Net Worth

Last updated:

What is Nathalie Adda net worth?

The estimated net worth of Dr. Nathalie Adda is at least $20,556,869 as of 4 Apr 2022. He owns shares worth $293,499 as insider, has earned $15,754,740 from insider trading and has received compensation worth at least $4,508,630 in Enanta Pharmaceuticals, Inc..

What is the salary of Nathalie Adda?

Dr. Nathalie Adda salary is $644,090 per year as Senior Vice President & Chief Medical Officer in Enanta Pharmaceuticals, Inc..

How old is Nathalie Adda?

Dr. Nathalie Adda is 59 years old, born in 1966.

What stocks does Nathalie Adda currently own?

As insider, Dr. Nathalie Adda owns shares in one company:

Company Title Shares Price per share Total value
Enanta Pharmaceuticals, Inc. (ENTA) Senior Vice President & Chief Medical Officer 34,982 $8.39 $293,499

What does Enanta Pharmaceuticals, Inc. do?

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

ENTA logo
ENTA
Enanta Pharmaceuticals, Inc.
$8.39

Nathalie Adda insider trading

Enanta Pharmaceuticals, Inc.

Dr. Nathalie Adda has made 26 insider trades between 2018-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 42,260 units of ENTA stock on 1 Apr 2022. As of 4 Apr 2022 he still owns at least 34,982 units of ENTA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 16,875 $63.35 $1,069,031
Option
Stock Option (Right to Buy) 9,625 $43.57 $419,361
Option
Stock Option (Right to Buy) 16,875 $63.35 $1,069,031
Option
Common Stock 6,285 $48.52 $304,948
Sale
Common Stock 2,500 $70.56 $176,400
Sale
Common Stock 18,076 $71.71 $1,296,230
Option
Stock Option (Right to Buy) 2,895 $48.52 $140,465
Sale
Common Stock 3,200 $72.65 $232,480
Option
Stock Option (Right to Buy) 6,285 $48.52 $304,948
Sale
Common Stock 9,009 $73.42 $661,441
Option
Common Stock 9,625 $43.57 $419,361
Option
Common Stock 16,000 $31.42 $502,720
Sale
Common Stock 8,299 $70.75 $587,154
Sale
Common Stock 42,260 $71.32 $3,013,983
Option
Common Stock 2,895 $48.52 $140,465
Option
Common Stock 31,664 $30 $949,920
Option
Stock Option (Right to Buy) 24,339 $43.46 $1,057,773
Option
Common Stock 12,481 $43.46 $542,424
Sale
Common Stock 12,481 $70.07 $874,544
Option
Stock Option (Right to Buy) 12,481 $43.46 $542,424
Option
Common Stock 24,339 $43.46 $1,057,773
Sale
Common Stock 100 $71.06 $7,106
Sale
Common Stock 24,239 $70.26 $1,703,032
Option
Common Stock 3,336 $30 $100,080
Option
Stock Option (Right to Buy) 3,336 $30 $100,080
Option
Stock Option (Right to Buy) 9,200 $43.46 $399,832
Option
Common Stock 9,200 $43.46 $399,832
Sale
Common Stock 12,536 $70.13 $879,150
Sale
Common Stock 201 $90.17 $18,124
Option
Stock Option (Right to Buy) 8,750 $43.46 $380,275
Option
Common Stock 8,750 $43.46 $380,275
Sale
Common Stock 1,587 $84.81 $134,593
Sale
Common Stock 5,736 $85.49 $490,371
Option
Common Stock 4,773 $48.52 $231,586
Sale
Common Stock 2,700 $86.45 $233,415
Option
Stock Option (Right to Buy) 4,773 $48.52 $231,586
Sale
Common Stock 1,500 $87.6 $131,400
Sale
Common Stock 900 $88.31 $79,479
Sale
Common Stock 899 $89.33 $80,308
Option
Common Stock 9,547 $48.52 $463,220
Sale
Common Stock 9,547 $85.18 $813,213
Option
Stock Option (Right to Buy) 9,547 $48.52 $463,220
Option
Common Stock 4,047 $43.46 $175,883
Option
Stock Option (Right to Buy) 17,500 $43.46 $760,550
Sale
Common Stock 4,047 $70.35 $284,686
Sale
Common Stock 13,453 $70.09 $942,934
Option
Common Stock 13,453 $43.46 $584,667
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Units 5,250 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Units 5,250 N/A N/A
Option
Stock Option (Right to Buy) 2,955 $43.46 $128,424
Option
Common Stock 2,955 $43.46 $128,424
Sale
Common Stock 4,155 $94.88 $394,231
Option
Common Stock 2,955 $43.46 $128,424
Sale
Common Stock 4,155 $92.06 $382,518
Option
Stock Option (Right to Buy) 2,955 $43.46 $128,424
Option
Common Stock 2,955 $43.46 $128,424
Option
Stock Option (Right to Buy) 2,955 $43.46 $128,424
Sale
Common Stock 9,200 $124.98 $1,149,807
Sale
Common Stock 4,155 $114.96 $477,659
Option
Common Stock 2,955 $43.46 $128,424
Option
Stock Option (Right to Buy) 2,955 $43.46 $128,424
Sale
Common Stock 4,155 $84.04 $349,174
Option
Common Stock 2,955 $43.46 $128,424
Option
Stock Option (Right to Buy) 2,955 $43.46 $128,424
Option
Stock Option (Right to Buy) 2,955 $43.46 $128,424
Option
Common Stock 2,955 $43.46 $128,424
Sale
Common Stock 4,225 $85.52 $361,309

Enanta Pharmaceuticals key executives

Enanta Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: